In July 2021, our performance-improved CAD4TB 7 received its CE certification to use on patients age 4 years and above, and it is clinically available.
Moreover, CAD4TB platform has now included new patient data management and dashboard functionalities for easy monitoring of the patient data
and screening progress. This new feature enables users to rapidly screen risk groups and support prevalence surveys, and collect all information into one platform.
CAD4TB, the world’s most validated and implemented CAD software for tuberculosis screening is also now available through the GDF Catalogue endorsed by the WHO with pre-negotiated prices.
